PARVA (parvin alpha) is a crucial scaffolding protein that plays essential roles in actin cytoskeleton organization and cell adhesion. As a component of the IPP (ILK-PINCH-PARVIN) complex, PARVA binds to F-actin and promotes F-actin bundling, which is required to generate force for actin cytoskeleton reorganization and dynamic cell adhesion events such as cell spreading and migration 1. The protein localizes to focal adhesions and functions through interactions with partners including integrin-linked kinase (ILK), paxillin, and alpha-actinin 1. PARVA exhibits regulatory functions by inhibiting the activities of Rac1 and testicular kinase 1, and can inhibit cell spreading 1. The ILK-PINCH-PARVA complex is critical for cell survival across various cell types, including cancer cells, kidney podocytes, and cardiac myocytes 1. In disease contexts, PARVA dysfunction contributes to vascular pathology, as demonstrated by altered phosphorylation patterns in vascular smooth muscle cells from patients with abdominal aortic aneurysm 2. Additionally, PARVA-dependent signaling is implicated in kidney development, where loss of interaction between ARHGEF6 mutants and PARVA contributes to congenital anomalies of the kidneys and urinary tract 3.